Physician profile
Marc E Munoz
NPI 1508831728
$960.02
in general payments reported to CMS, 2019-2025
16 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $162 · 2022: $38.87 · 2024: $18.64 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $342.22 | 2019-2022 | |
| Stryker Corporation | $154.98 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $116.87 | 2019-2020 | |
| Allergan, INC. | $74.07 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.94 | 2019-2020 | |
| Ucb, INC. | $41.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.32 | 2019 | |
| Insmed, INC. | $30.50 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.64 | 2024 | Lifevest |
| Tetraphase Pharmaceuticals, INC. | $17.83 | 2020 | |
| Amgen INC. | $15.39 | 2019 | |
| Pfizer INC. | $15.05 | 2019 | |
| Pharming Healthcare, INC. | $14.10 | 2022 | |
| Medtronic USA, INC. | $13.52 | 2019 | |
| Biomerieux INC | $11.84 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.